Clinical Trials Logo

Filter by:
NCT ID: NCT04789304 Completed - Healthy Clinical Trials

A Study to Test How Healthy Men Tolerate Different Doses of BI 1595043

Start date: April 1, 2021
Phase: Phase 1
Study type: Interventional

The primary objectives of this trial are to investigate safety and tolerability of BI 1595043 in healthy male subjects following administration of multiple rising doses over 14 days. Secondary objectives are the exploration of pharmacokinetics (PK) of BI 1595043 after single and multiple dosing.

NCT ID: NCT04789291 Completed - Healthy Clinical Trials

A Study in Healthy Men to Test How BI 1595043 is Taken up in the Body When Given With or Without Food

Start date: May 18, 2021
Phase: Phase 1
Study type: Interventional

The main objective of this trial is to investigate the relative bioavailability of BI 1595043 under fed state (Test, T) and under fasted state (Reference, R).

NCT ID: NCT04788069 Completed - Energy Intake Clinical Trials

Effect of Sourdough Breads Consumption on Postprandial Responses, Satiety and Food Intake at Subsequent Meal

SUPPRESS
Start date: June 1, 2021
Phase: N/A
Study type: Interventional

During this project the effect of different types of sourdough breads consumption on satiety, energy intake at subsequent meal and postprandial metabolic responses, will be investigated.

NCT ID: NCT04787302 Completed - Schizophrenia Clinical Trials

PET Trial to Evaluate Target Occupancy of CVL-231 on Brain Receptors Following Oral Dosing

Start date: June 1, 2021
Phase: Phase 1
Study type: Interventional

PET Trial to Evaluate Target Occupancy of CVL-231 at Muscarinic Receptors Type 4 in Brain Following Oral Dosing

NCT ID: NCT04786834 Completed - Clinical trials for Educational Problems

PBP Versus Halsted's Model: the PROVESA Trial

PROVESA
Start date: July 27, 2020
Phase: N/A
Study type: Interventional

This randomized controlled trial aims to compare the effectiveness of Halsted's apprenticeship approach to training with the PBP approach for teaching the robotic suturing of a VUA on a chicken model.

NCT ID: NCT04784650 Completed - Diabetes Mellitus Clinical Trials

The Prevalence of Foot Complaints/Problems and Ulcers in a Pre-dialysis Population

Start date: January 31, 2021
Phase: N/A
Study type: Interventional

Diabetes mellitus is one of the main causes of chronic kidney disease (CKD) and an increased risk of foot complications is seen in patients suffering from both DM and CKD. CKD and DM patients share a trilogy of risk factors that contribute to the development of foot ulcers. This trilogy consists of peripheral arterial disease (PAD), neuropathy and an increased susceptibility to infection with an impaired wound healing. Additionally, almost one quarter of adults with CKD have to cope with depression. The aim of our study is to determine the prevalence and types of foot problems in a pre-dialysis population, consisting of both DM and non-DM patients. If possible, risk factors will be determined. The detrimental effects of poor kidney function and foot problems on the quality of life and the general health status will be analyzed. A higher prevalence of PAD, peripheral neuropathy and DM are expected in patients with foot problems compared to those without.

NCT ID: NCT04784013 Completed - Atrial Fibrillation Clinical Trials

Very High Power Ablation in Patients With Atrial Fibrillation Scheduled for a First Pulmonary Vein Isolation

POWER-PLUS
Start date: March 24, 2021
Phase: Phase 4
Study type: Interventional

This prospective, randomized, controlled, unblinded, multicenter study aims at comparing procedural time between conventional CLOSE-guided pulmonary vein isolation (PVI) (35W/50W) versus very high power radiofrequency delivery (90W) in atrial fibrillation patients scheduled for a first PVI.

NCT ID: NCT04782934 Completed - Diabetes Mellitus Clinical Trials

The GLOW Study - The YANG System

Start date: February 25, 2021
Phase: N/A
Study type: Interventional

This is an open label, interventional, monocentric, prospective early feasibility study, designed to evaluate the safety of implant and short-term integration into the tissue of the YANG sensor. In addition, the set up will enable data collection which will be used to develop the software algorithm to allow real-time, continuous measurement of glucose, ketone and lactate levels in the interstitial fluid in adults with diabetes mellitus, in a future version of the device.

NCT ID: NCT04780763 Completed - Clinical trials for Anxious Healthy Subjects

Effect of 4-week Oral Administration of a Fermented Dairy Product Containing Lactobacillus Rhamnosus CNCM I-3690, on Subjective State Anxiety Levels in Healthy Women Undergoing Academic Stress.

Tara
Start date: March 4, 2021
Phase: N/A
Study type: Interventional

The purpose of this study is to assess the effect of Lactobacillus rhamnosus CNCM I-3690 consumption on subjective anxiety levels in healthy subjects undergoing academic stress.

NCT ID: NCT04779749 Completed - Covid19 Clinical Trials

Pregnancy Outcomes According to the Gestational Age of Acquiring COVID-19

Start date: December 8, 2020
Phase:
Study type: Observational

A new coronavirus, called severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) appeared in Wuhan, China and it arrived to Europe 2-3 months later. It infected millions of persons and led to the death of thousands until May 2020 where numbers of infections per week decreased significantly. However, starting September, number of infections started to escalate again and continued to rise until now. Hundreds of good quality articles were published during this period to study the relationship and effects of this virus on pregnancy and vice versa, as well as to determine the adverse neonatal and obstetrical outcomes following the infection. In a case-control study using propensity score matching at the level of age, body mass index and comorbidities (diabetes, hypertension, asthma), pregnant women over 20 week's gestation had significantly higher risk for intensive care unit stay, endotracheal intubation, hospitalization for disease related symptoms and need for oxygen therapy. A new systematic review also demonstrated increased risk for ICU admission in pregnant women compared to non-pregnant women and to non-infected pregnant women. On the other hand, many researchers have demonstrated that the rates of preterm delivery and cesarean delivery have increased as well, others reported a close relation between SARS-CoV2 infection and preeclampsia or preeclampsia like condition. Enormous effort was done in order to understand adverse outcomes related to this infection, however, most studies included patients in the third or late second trimester. Few studies stratified adverse outcomes of the patients according to the trimester of infection.